Home
Conditions
Myasthenia Gravis

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

259 public trials 95 recruiting studies

Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Not Yet Recruiting

Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis

NCT07243366

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG

NCT07226830

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: Massachusetts General Hospital, Neuromuscular Diagnostic Center Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis

NCT07224386

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations: Massachusetts General Hospital, Neuromuscular Diagnostic Center Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Integrating Art Therapy and Adapted Physical Activity: Toward Improved Quality of Life in Patients With Myasthenia Gravis

NCT07125105

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Lille University Hospital Lille, Hauts-de-France, France

View Trial Details

Not Yet Recruiting

Efgartigimod for Consolidation Therapy in gMG

NCT07079020

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

NCT06978738

Conditions: ANCA-associated Vasculitis, Anemia, Anemia, Hemolytic, +36 more
Locations: Changzhou No.2 People's Hospital Changzhou, China

View Trial Details

Not Yet Recruiting

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

NCT06933563

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Blinatumomab for Treatment of Refractory Myasthenia Gravis

NCT06836973

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

NCT06827587

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis

NCT06759948

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +11 more
Locations: Huashan Hospital, affiliated to Fudan University, Shanghai, Shanghai, Shanghai Municipality, China

View Trial Details

Myasthenia Gravis

Myasthenia Gravis trial results

Related conditions